211 related articles for article (PubMed ID: 32239697)
1. Allergen-specific subcutaneous immunotherapy for Japanese cedar pollinosis decreases the number of metachromatic cells and eosinophils in nasal swabs during the preseason and in season.
Otsuka K; Otsuka H; Matsune S; Okubo K
Immun Inflamm Dis; 2020 Sep; 8(3):258-266. PubMed ID: 32239697
[TBL] [Abstract][Full Text] [Related]
2. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
Otsuka K; Otsuka H; Matsune S; Okubo K
Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
[TBL] [Abstract][Full Text] [Related]
3. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M
Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Staphylococcus aureus and Moraxella catarrhalis in Japanese cedar pollinosis.
Otsuka H; Takanashi I; Tokunou S; Endo S; Okubo K
Am J Rhinol Allergy; 2016; 30(2):99-106. PubMed ID: 26877537
[TBL] [Abstract][Full Text] [Related]
5. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis.
Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H
Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319
[TBL] [Abstract][Full Text] [Related]
6. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
7. Quantitative cytology of nasal secretions and scrapings in Japanese cedar pollinosis patients.
Takeuchi K; Ukai K; Lee HS; Majima Y; Sakakura Y
Laryngoscope; 1996 Nov; 106(11):1419-23. PubMed ID: 8914913
[TBL] [Abstract][Full Text] [Related]
8. Effect of Japanese cedar specific immunotherapy on allergen-specific T(H)2 cells in peripheral blood.
Nomura T; Tsuge I; Inuo C; Nakajima Y; Tanaka K; Naruse N; Suzuki S; Ando H; Kondo Y; Saitoh S; Urisu A
Ann Allergy Asthma Immunol; 2013 May; 110(5):380-385.e1. PubMed ID: 23622011
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
[TBL] [Abstract][Full Text] [Related]
10. Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis.
Terada T; Omura S; Kikuoka Y; Suzuki M; Inaka Y; Inui T; Matsuda M; Nabe T; Kawata R
Rhinology; 2020 Jun; 58(3):241-247. PubMed ID: 32091032
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
Ito Y; Takahashi Y; Fujita T; Fukuyama S
Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
[TBL] [Abstract][Full Text] [Related]
12. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
Noyama Y; Okano M; Fujiwara T; Kariya S; Makihara S; Haruna T; Kanai K; Higaki T; Nishizaki K
Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
[TBL] [Abstract][Full Text] [Related]
13. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
Suzuki M; Yokota M; Ozaki S; Matsumoto T; Nakamura Y
Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
[TBL] [Abstract][Full Text] [Related]
14. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.
Wilson DR; Irani AM; Walker SM; Jacobson MR; Mackay IS; Schwartz LB; Durham SR
Clin Exp Allergy; 2001 Nov; 31(11):1705-13. PubMed ID: 11696046
[TBL] [Abstract][Full Text] [Related]
15. Nasal allergen-neutralizing IgG
Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
[TBL] [Abstract][Full Text] [Related]
16. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
17. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
Okuda M; Ohkubo K; Gotoh M; Ishida Y
Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
[TBL] [Abstract][Full Text] [Related]
18. Seasonal variation of nasal surface basophilic cells and eosinophils in Japanese cedar pollinosis.
Liu CM
Rhinology; 1988 Sep; 26(3):167-73. PubMed ID: 3194630
[TBL] [Abstract][Full Text] [Related]
19. Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment.
Osada T; Okano M
Allergol Int; 2021 Jul; 70(3):281-290. PubMed ID: 33962864
[TBL] [Abstract][Full Text] [Related]
20. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
